PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
NCT04767802
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Polycythemia Vera
Interventions
DRUG:
PTG-300
Sponsor
Protagonist Therapeutics, Inc.